The Gold Trade, May 24
Health Care: Drugs
Charles River Laboratories International In (CRL: NYSE)
$44.39 0.04 | 0.09%
05/24/13 - 04:02 PM ET
166.04K / 572.30K
Vol / Avg. Vol:44.17 / 44.35
Open / Prev. Close:43.68 - 44.54
Today's Range:31.48 - 46.90
52 Wk Range:17.48%
Performance YTD:TheStreet Rating:
Portfolios with CRL
- Portfolio NameUser Type
- ProDavid Dreman
- Contributor10 Top Morningstar M&A Stoc...
- Contributor8 Biotech Stocks to Watch
- ContributorCramer's Market Gifts
- ContributorBarron's Activist Stocks 6-...
- UserTrading Stocks - Recommenda...
- ContributorBarron's Activist Stocks 6-...
- UserPART 5 JPMorgan 28th Annual...
- Userstocks4me#3
- UserLingo Holdings
Latest CRL Headlines from TheStreet
- Cramer's 'Mad Money' Recap: A Surreal Market 05.13.13 | 08:05 pm
- Cramer's 'Mad Money' Recap: Next Week's Game Plan (Correct) 05.03.13 | 07:05 pm
- Cramer's Top Stock Picks: AGN BP CRL PRU AIG 05.03.13 | 06:05 am
- Cramer's 'Mad Money' Recap: A New Dawn for Europe? 05.02.13 | 08:05 pm
- Cramer's 6 Stocks in 60 Seconds: CRL TUMI DLTR LM PNRA VLO 04.03.13 | 11:04 am
- 10 Biotech Stocks With A History Of Beating Earning Expectations 01.10.13 | 07:01 pm
- Cramer's Top Stock Picks: UTX ACOR CRL AA 01.10.13 | 06:01 am
- Cramer's 'Mad Money' Recap: Bright Spots 01.09.13 | 07:01 pm
- Analysts' Actions: ADI BKW CMA RIMM PFE 12.13.12 | 09:12 am
- Cramer's 'Mad Money' Recap: A Market of Mixed Signals 08.13.12 | 08:08 pm
Press Releases for CRL
- Charles River Laboratories To Present At March Investor Conferences - Business Wire 03.01.13 | 09:03 am
- Charles River Laboratories Announces Fourth-Quarter And Full-Year 2012 Results From Continuing Operations - Business Wire 02.13.13 | 04:02 pm
- Charles River Laboratories Schedules Fourth-Quarter And Full-Year 2012 Earnings Release And Conference Call - Business Wire 01.22.13 | 09:01 am
- Charles River Laboratories Completes Acquisition Of Majority Ownership Of Vital River - Business Wire 01.07.13 | 05:01 pm
- Charles River Laboratories To Present At J.P. Morgan Healthcare Conference - Business Wire 01.07.13 | 08:01 am
- Charles River Laboratories Provides 2013 Financial Guidance - Business Wire 12.12.12 | 07:12 am
- Charles River Laboratories Schedules 2013 Guidance Release And Conference Call - Business Wire 11.29.12 | 04:11 pm
- Charles River Laboratories Announces Third-Quarter 2012 Results From Continuing Operations - Business Wire 10.30.12 | 04:10 pm
- Charles River Laboratories To Expand Research Models Business In China - Business Wire 10.30.12 | 04:10 pm
- Charles River Laboratories Enters Strategic Partnership With AstraZeneca - Business Wire 10.17.12 | 08:10 am
Partner Headlines for CRL
- Vivus Expects European Setback - Analyst Blog - NASDAQ 09.25.12 | 08:09 pm
- DRRX - Initiating Coverage of DURECT Corp. - Analyst Blog - NASDAQ 09.11.12 | 02:09 pm
- Another Delay for Salix Candidate - Analyst Blog - NASDAQ 09.10.12 | 10:09 pm
- Charles River Purchases Accugenix - Analyst Blog - NASDAQ 08.31.12 | 10:08 pm
- Charles River Purchases Accugenix - Analyst Blog - Zacks 08.31.12 | 06:08 pm
- Good News for Alexza Pharma - Analyst Blog - NASDAQ 08.23.12 | 02:08 pm
- Salix Pharma at Neutral - Analyst Blog - NASDAQ 08.21.12 | 09:08 pm
- UPDATE: Sterne Agee Raises PT to $45 on Charles River Laboratories - Benzinga 04.02.12 | 09:04 am
- Earnings Rise at Charles River - Analyst Blog - Zacks 02.14.12 | 10:02 am
- 10 Biotech Stocks With Strong Corporate Governance - Seeking Alpha 01.18.12 | 09:01 am
